hyperplasia/homa

Kiungo kimehifadhiwa kwenye clipboard

Chagua aina ya aina

Ukurasa 1 kutoka 684 matokeo

Hyperthermia and thermotherapy of benign prostatic hyperplasia: a critical review.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

The indications, risks and benefits of surgical treatment of benign prostatic hyperplasia (BPH) have recently been scrutinized, and interest in the development of less invasive alternative nonsurgical approaches has emerged. Among the nonsurgical alternatives, thermal treatments have been clinically

Localised deep microwave hyperthermia in the treatment of benign prostatic hyperplasia: long-term assessment.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

A group of 133 patients with benign prostatic hyperplasia who were either poor operative risks or who had refused surgery underwent localised deep microwave hyperthermia, without supplementary drugs. In 59% of patients who had had an indwelling catheter, freedom from urological obstruction and

Transurethral hyperthermia for benign prostatic hyperplasia: long term results.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Transurethral resection of the prostate (TURP) is the only recognized treatment in patients with benign prostatic hyperplasia (BPH). Transurethral hyperthermia (TUHT) was used as an alternative treatment in patient who refused TURP. From 1987 to 1988, 21 BPH patients with moderate to severe symptoms

Treatment of benign prostatic hyperplasia causing complete urinary retention through local transurethral hyperthermia.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

A new technique is described for the treatment of benign prostatic hyperplasia with local hyperthermia applied transurethrally by an electromagnetic wave generator. A series of 72 treatment sessions given to 16 patients sustaining an indwelling catheter is reported. The patients were divided into

[Seizures associated with fever in children of congenital adrenal hyperplasia].

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

We investigated seizures in 22 children with congenital adrenal hyperplasia (CAH), eight of whom had seizures associated with fever. The follow-up period was 5-18 years. The onset of seizures ranged from 1 to 4 years of age, and the total number of seizures was one to three in all cases. Four cases

Comparative study between the use of a treatment with hyperthermia through the rectal approach versus the urethral approach for benign prostatic hyperplasia.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

200 patients suffering from benign prostatic hyperplasia were treated with hyperthermia: 100 cases through the rectal approach and 100 through the urethral approach. Subjective symptoms were assessed as well as nycturia and objective data, urinary flow and postmicturition residue before treatment

Transrectal microwave hyperthermia for patients with benign prostatic hyperplasia.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND A randomized study evaluated the efficacy of treatment with transrectal microwave hyperthermia (TMH) treatment in patients with benign prostatic hyperplasia (BPH). METHODS Eighty BPH patients received TMH therapy and 20 patients were given a sham treatment. TMH was achieved using a

[New microwave transurethral hyperthermia for benign prostatic hyperplasia--clinical evaluation].

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Several types of hyperthermic apparatuses are employed to treat benign prostatic hyperplasia (BPH). As the prostate surrounds the urethra, we believed that transurethral heating allowed for more efficient and uniform heating. A new effective apparatus for this objective was developed. The size of

Treatment response with transurethral microwave hyperthermia in different forms of benign prostatic hyperplasia: a preliminary report.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

During a 7-month period, 79 patients with benign prostatic hyperplasia (BPH) were treated with 915 MHz transurethral hyperthermia (TUHT). All patients had obstructive and irritative signs and symptoms which warranted surgical treatment considerations. Of the 79 patients treated, 31 had follow-ups of

Results of deep prostatic hyperthermia applied with Thermex II in 525 benign prostatic hyperplasias.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Deep prostatic hyperthermia (DPH) with radiofrequency waves has been found to be of considerable beneficial value in benign prostatic hyperplasia. This study was performed on 525 patients. Madsen's criteria were used for symptom scoring. All the treatments were performed at 44.5 degrees C. Mean

A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative risk.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Transrectal hyperthermia, transurethral thermotherapy, prostatic stent, and prostatic spiral were used to treat 120 poor operative risk patients with symptomatic benign prostatic hyperplasia. The preoperative subjective and objective conditions of the four groups (each of 30 patients) were

Serum prostate specific antigen levels during hyperthermia treatment of benign prostatic hyperplasia.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

To understand better the tissue and cell changes occurring in the human prostate as a reaction to heat, we used circulating prostate specific antigen as a marker to detect cell injury. The prostate in 18 patients with benign prostatic hyperplasia was heated to 42 +/- 1.5C with local microwaves at

[Transrectal hyperthermia in the treatment of benign prostatic hyperplasia].

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

A group of 53 patients with benign prostatic hyperplasia underwent transrectal hyperthermia using Prostathermer (Biodan) from September 1992 to March 1993. 41 of the 53 patients were followed up for 6 months. The subjective symptoms improved in 75.6% (31/41) of the treated patients. The mean maximum

Efficacy of transurethral hyperthermia in benign prostatic hyperplasia.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

From February 1990 through May 1991, 37 patients with benign prostatic hyperplasia were treated by transurethral hyperthermia according to two different protocols. In group I, 10 patients with an indwelling catheter underwent six one-hour sessions twice a week for three weeks, at a temperature of 43

Transrectal hyperthermia-induced histological and ultrastructural changes of human benign prostatic hyperplasia tissue.

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This prospective study evaluated the tissutal, cellular and intracellular effects of transrectal microwave hyperthermia on human benign prostatic hyperplasia. Forty-eight patients with benign prostatic hyperplasia underwent ten 60-min-long sessions of transrectal hyperthermia with an intraprostatic

Iliyotangulia
1
2
3
4
5
6
...
45
46
Ifuatayo

Jiunge na ukurasa
wetu wa facebook

Herbal & Natural Medicine

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

Inafanya kazi katika lugha 55
Uponyaji wa mitishamba unaungwa mkono na sayansi
Kutambua mimea kwa picha
Ramani ya GPS inayoshirikiana
Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
Tafuta mimea ya dawa na athari zao
Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa